retatrutide phase 2 trial results weight loss just delivered the first top-line 3 for a triple agonist in obesity — and the findings from TRIUMPH-4 are striking👇 Difference between tirzepatide and retatrutide:

Amycretin oral formulations helped patients lose up to 13.1% of their weight within 12 weeks

General storage recommendations include: Store unopened lyophilised vials in a cool environment

Targeting metabolism, insulin resistance, and diabetes to treat nonalcoholic steatohepatitis

What actions can health insurers take now

Direct Comparison Studies While large head-to-head trials specifically comparing these medications for weight loss are limited, the SUSTAIN 10 trial compared them for diabetes: SUSTAIN 10 results: Semaglutide 1mg vs

one common approach began at 0.5 mg once weekly , with incremental increases at approximately four-weekly intervals up to target maintenance doses of 4 mg, 8 mg, or 12 mg once weekly